Abstract 243: Chloroquine Treatment Increases the Threshold of Aortic Contractile Responses to Norepinephrine in a Nitric Oxide Synthase-dependent Manner in Spontaneously Hypertensive Rats

Hypertension ◽  
2013 ◽  
Vol 62 (suppl_1) ◽  
Author(s):  
Cameron G McCarthy ◽  
Camilla F Wenceslau ◽  
Styliani Goulopoulou ◽  
Kathryn Spitler ◽  
Takayuki Matsumoto ◽  
...  

Toll-like receptors (TLRs) are pattern recognition receptors of the innate immune system that are located either on the plasma membrane or on membrane of endosomes. TLR activation in immune cells leads to a pro-inflammatory phenotype and TLRs have been associated with the development of hypertension. However, the role of TLRs in the development of vascular dysfunction, a hallmark of hypertension, has not been extensively investigated. Chloroquine (CQ), due to its ability to inhibit autophagy and block lysosomal degradation, has been used as a non-specific inhibitor of TLRs located on endosomes. We hypothesized that treatment with CQ (40mg/kg/day) for 21 days would attenuate aortic contractile responses in young spontaneously hypertensive rats (SHRs; 5-6 weeks old) compared to saline (Veh) control. Concentration response curves to norepinephrine (NE; 10 -11 -10 -6 M), in the presence or absence of nitric oxide synthase (NOS) inhibitor L-NNA (10 -4 M), were performed in isolated aortic rings ex vivo on a pin myograph. CQ increases the threshold of aortic contractile responses to NE compared to Veh (logEC 20 CQ: -8.8±0.1 vs. Veh: -9.6±0.3, p<0.05). In the presence of L-NNA, there was a significant difference between CQ and CQ+L-NNA (logEC 20 CQ: -8.8±0.1 vs. CQ+L-NNA: -9.4±0.2, *p<0.05) (A); however, this difference was absent between Veh and Veh+L-NNA (logEC 20 Veh: -9.4±0.3 vs. Veh+L-NNA: -10.0±0.4, p>0.05) (B). These data illustrate that CQ improves the threshold for SHR aortic contraction to NE by preserving NO. Therefore, maintenance of NOS activity and NO bioavailability by inhibition of endosomal TLRs could be a therapeutic target against the development of hypertension.

1997 ◽  
Vol 756 (1-2) ◽  
pp. 61-67 ◽  
Author(s):  
Yasuko Sakurai-Yamashita ◽  
Kimihiro Yamashita ◽  
Yasufumi Kataoka ◽  
Akihiko Himeno ◽  
Masami Niwa ◽  
...  

Stroke ◽  
2020 ◽  
Vol 51 (9) ◽  
pp. 2834-2843
Author(s):  
Daniel J. Beard ◽  
Zhaojin Li ◽  
Anna M. Schneider ◽  
Yvonne Couch ◽  
Marilyn J. Cipolla ◽  
...  

Background and Purpose: Rapamycin is a clinically approved mammalian target of rapamycin inhibitor that has been shown to be neuroprotective in animal models of stroke. However, the mechanism of rapamycin-induced neuroprotection is still being explored. Our aims were to determine if rapamycin improved leptomeningeal collateral perfusion, to determine if this is through eNOS (endothelial nitric oxide synthase)-mediated vessel dilation and to determine if rapamycin increases immediate postreperfusion blood flow. Methods: Wistar and spontaneously hypertensive rats (≈14 weeks old, n=22 and n=15, respectively) were subjected to ischemia by middle cerebral artery occlusion (90 and 120 minutes, respectively) with or without treatment with rapamycin at 30-minute poststroke. Changes in middle cerebral artery and collateral perfusion territories were measured by dual-site laser Doppler. Reactivity to rapamycin was studied using isolated and pressurized leptomeningeal anastomoses. Brain injury was measured histologically or with triphenyltetrazolium chloride staining. Results: In Wistar rats, rapamycin increased collateral perfusion (43±17%), increased reperfusion cerebral blood flow (16±8%) and significantly reduced infarct volume (35±6 versus 63±8 mm 3 , P <0.05). Rapamycin dilated leptomeningeal anastomoses by 80±9%, which was abolished by nitric oxide synthase inhibition. In spontaneously hypertensive rats, rapamycin increased collateral perfusion by 32±25%, reperfusion cerebral blood flow by 44±16%, without reducing acute infarct volume 2 hours postreperfusion. Reperfusion cerebral blood flow was a stronger predictor of brain damage than collateral perfusion in both Wistar and spontaneously hypertensive rats. Conclusions: Rapamycin increased collateral perfusion and reperfusion cerebral blood flow in both Wistar and comorbid spontaneously hypertensive rats that appeared to be mediated by enhancing eNOS activation. These findings suggest that rapamycin may be an effective acute therapy for increasing collateral flow and as an adjunct therapy to thrombolysis or thrombectomy to improve reperfusion blood flow.


Sign in / Sign up

Export Citation Format

Share Document